Abstract 319 Table 1
Year Published First Author Study Location Number of Patients Number of Recurrent Cases Time Between First and Second Episode Factors During Initial Episode Associated with Increased Risk of Recurrence
2012 Chahal* Canada 1010 17 in 16 patients (1.7%) Average: 1.5 years Longer duration of fever before diagnosis (p=0.01) and total duration of fever (p=0.02)
Lower median albumin (p=0.03)
Higher white blood cell count (p=0.05)
2001 Hirata* Japan 10 679 217 (2.0%) Range: 2–11 months Presence of cardiac sequelae within 1 year (hazard ratio: 1.77–4.39)
2015 Maddox United States 5557 97 (1.7%) Average: 22.5 months Coronary artery abnormality (p=0.01)
Atypical KD cases (p=0.006)
2015 Maddox United States 13 874 483 (3.5%) Not Reported Being Asian/Pacific Islander (hazard ratio: 1.4–3.7)
Rash (p=0.03) and cervical lymphadenopathy (p<0.001)
Coronary artery abnormailty (p=0.003)
Atypical KD (p=0.01)
2017 Sudo Japan 81 310 1842 (2.3%) Range: within 2 years Being male (hazard ratio: 1.01–1.21)
Steroid therapy (hazard ratio: 1.14–1.70)
Resistance to IVIG (hazard ratio: 1.18–1.67)
2013 Yang* China 1173 22 (1.9%) Average: 12 months Being female (p=0.026)
Longer duration of fever before IVIG treatment (p<0.001)
Lower hemoglobin level (p<0.001)
Higher ALT (p=0.032) and AST (P
Coronary artery abnormality (p=0.035)
  • *Studies that included laboratory values as risk factors for recurrence.